Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Waiting for filing.
Sell 10,000 shares of SYEV for the SwingTrade Portfolio. I don't know if the results can be repeated. Therefore, I'll take the profit and reevaluate on future results or once I get more information.
michael t re: MTSL....
Some comments on your analysis:
1. You are comparing apples and oranges on revenue. The $4.2M in revenue that reported in Q1 was gross revenue. Gross revenue in Q2 was $3.4M. So, the sequential drop in revenue was $0.8M and not $1.1M as you report. See the Q1 and Q2 reports for details.
2. The pro-forma numbers which break out Vexigo's contribution for the first three quarters of 2014 show operating expenses of $736K. So, $350K in incremental operating expenses is in the ballpark. Also, we really don't know what the operating expense mix is between the old part of MTSL and Vexigo for Q2. So, we have to be careful about how we draw conclusions. The pro-forma financials can be found in the 6-K from 2/18.
3. Selling and marketing expenses in the pro-forma for the first three quarters of 2014 are $22K for Vexigo and $1.356M for MTSL. They don't have much in the way of selling and marketing expenses. They appear to be a small organization so people probably wear many hats. I suspect that management also, does some selling and their costs end out in G&A.
Good news!
AmpliPhi BioSciences Cleared to Submit Listing Application to NYSE MKT
Company Announces One-for-Fifty Reverse Stock Split
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis onAugust 07, 2015
SAN DIEGO & RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY--(BUSINESS WIRE)--
AmpliPhi BioSciences Corporation (APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug resistant infections, today announced that its board of directors has approved a one-for-fifty reverse split of the company’s common stock to become effective at market open on August 07, 2015. The company has also been cleared to submit an application to the NYSE MKT for a planned uplisting. AmpliPhi’s eligibility is subject to NYSE MKT rules and regulations and maintaining a minimum market price per share for a specified time period as determined by the NYSE.
“We believe that the reverse stock split will facilitate our listing to a major national exchange, and by listing on a national exchange we will significantly increase the marketability of the company’s common stock among both institutional and retail investors focused on national exchange-listed securities,” said M. Scott Salka, CEO of AmpliPhi. “Following our recent successful financing round in March 2015, AmpliPhi remains in a solid financial position to execute on its near-term corporate objectives and we expect that the reverse split will encourage greater interest in our Common Stock by the financial community and the investing public.”
The reverse stock split was authorized by shareholders on August 03, 2015 at the Company’s 2015 Annual Meeting. The reverse stock split is intended to increase the per share trading price of the company’s common stock to meet the minimum per share bid price required by NYSE MKT. The effect of the reverse stock split will be to combine each 50 shares of outstanding common stock into one new share, with no change in par value per share, and to reduce the number of common shares outstanding from approximately 289 million to approximately 5.8 million. On August 07, 2015, the Company’s stock will trade on the OTCQB under the symbol “APHBD”, with the “D” added to signify a reverse stock split has occurred.
Informational letters will be sent to all shareholders on record by the Company’s transfer agent, Computershare. Additional information about the reverse stock split can be found in the Company’s Form 8-K filed today with the Securities and Exchange Commission.
About AmpliPhi BioSciences
AmpliPhi BioSciences Corporation (APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics. The Company's product development programs target infections that are often resistant to existing antibiotic treatments. AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (XON), the U.S. Army, The Royal Brompton Clinic in London and The University of Leicester, UK to rapidly advance bacteriophage-based therapies.
For more information, visit www.ampliphibio.com.
About Bacteriophage
Bacteriophage are naturally occurring viruses that are highly specific for the bacterial hosts they infect. They can rapidly kill their host, amplifying themselves in the process. Bacteriophage are unaffected by antibiotic resistance and are able to disrupt bacterial biofilms. Such biofilms are a major line of defence for bacteria, contributing to antibiotic resistance. Bacteriophage are able to penetrate biofilms and replicate locally to high levels, to produce strong local therapeutic effects.
Forward Looking Statements
Statements in this press release about the potential listing of the Company’s common stock on the NYSE MKT, potential improvements in the marketability of the Company’s securities, the ability of the Company to execute on its near term objectives, the potential use of bacteriophages to treat bacterial infections, including infections in biofilms and infections that do not respond to antibiotics, and the development of bacteriophage-based therapies are forward looking statements subject to risks and uncertainties, including without limitation the risk that the Company will not satisfy the listing criteria of the NYSE MKT, that the trading price of the Company’s common stock may decline following the reverse split, that the Company will not be able to successfully manufacture sufficient quantities of products to conduct clinical trials or commercialize products in a timely manner or at all, that AmpliPhi may not commence clinical trials or complete IND-enabling studies as expected, that the clinical trials will not be successful, that further development of the Company's products will require extensive and expensive nonclinical and clinical testing, may not be safe or efficacious, and may not be approved for marketing by the United States Food and Drug Administration or any foreign regulatory agency. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to AmpliPhi's business in general, see AmpliPhi's Annual Report on Form 10-K for the fiscal year ended December 31, 2014, as amended, filed with the Securities and Exchange Commission (SEC) on April 15, 2015.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150804005466/en/
Contact:
Company and Investor relations:
AmpliPhi BioSciences Corporation
Baxter Phillips III
Chief Business Officer
+1-804-754-5442
bfp@ampliphibio.com
or
Media relations (USA)
Lazar Partners
Danielle Lewis/Glenn Silver
+1-212-867-1762
ampliphi@lazarpartners.com
or
Media Relations (Europe and ROW)
Instinctif Partners
Gemma Howe/Sue Charles
+44 (0)20 7457 2020
Ampliphi@instinctif.com
Payment Data Systems Announces Approval for Listing on NASDAQ
Begins Trading on the NASDAQ Capital Market on August 11, 2015
SAN ANTONIO, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Payment Data Systems, Inc. (OTCQB:PYDSD) (PYDS), announced that it has received confirmation that its application to list the Company's common stock on the NASDAQ Capital Market has been approved by The NASDAQ Stock Market, a unit of the NASDAQ OMX Group. In honor of the listing, the Company will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York City, on Monday, December 21, 2015
The Company's common stock is expected to begin trading on NASDAQ at the opening of trading on August 11, 2015 under the ticker symbol, PYDSD. The Company's common stock will continue to trade on the OTCBB and the OTCQB until market close on August 10, 2015 under the ticker symbol, PYDSD.
After 20 days, or on August 20, the Company's ticker symbol will revert to trading as PYDS from PYDSD on NASDAQ.
Michael Long, Chairman and CEO of Payment Data Systems stated, "Our listing on the NASDAQ Capital Market is a major corporate milestone for our Company and a testament to the tremendous progress we have made over the past few years. Furthermore, we believe that the listing on NASDAQ will help broaden our shareholder base, increase appeal to institutional investors, provide us with better liquidity and ultimately contribute to increasing shareholder value."
About Payment Data Systems, Inc.
Payment Data Systems is an integrated payment solutions provider to merchants and billers. The Company provides an extensive set of products to deliver world-class payment acceptance. Payment Data has solutions for merchants, billers, banks, service bureaus and card issuers. The strength of the Company is its ability to offer specifically tailored solutions for card issuance, payment acceptance and bill payments.
Through its wholly-owned subsidiary of FiCentive, Inc., a turn-key prepaid card solutions provider, that quickly and securely delivers customized prepaid card programs for corporations, financial institutions, affinity groups or any organization that needs to deliver a financial incentive to their customers, vendors, or employees.
The Company's proprietary platform boasts the highest level of security, encryption and card association compliance. The Company's prepaid card programs for many industries.
For additional information, visit www.paymentdata.com. Contact Michael Long for Investor Relations information at 210.249.4040 or email at ir@paymentdata.com.
Websites: www.paymentdata.com, www.ficentive.com, www.zbill.com
Find us on Facebook(R)
FORWARD-LOOKING STATEMENTS DISCLAIMER:
Except for the historical information contained herein, the matters discussed in this release include certain forward-looking statements, which are intended to be covered by safe harbors. Those statements include, but may not be limited to, all statements regarding our and management's intent, belief and expectations, such as statements concerning our future and our operating and growth strategy. Investors are cautioned that all forward-looking statements involve risks and uncertainties including, without limitation, the factors detailed from time to time in our filings with the Securities and Exchange Commission. One or more of these factors have affected, and in the future could affect our businesses and financial results in the future and could cause actual results to differ materially from plans and projections. We believe that the assumptions underlying the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. All forward-looking statements made in this release are based on information presently available to our management. We assume no obligation to update any forward-looking statements, except as required by law.
Contact:
Read my latest blog - The Three P's of Investing
http://microcapclub.com/2015/07/the-three-ps-of-investing/
Kirin International Submits Application to Trade on NASDAQ
NEW YORK, July 30, 2015 (GLOBE NEWSWIRE) -- Kirin International Holdings Inc. (KIRI) (the "Company"), a non-state-owned real estate development company focused on residential and commercial real estate development in "tier-three" cities in the People's Republic of China, today announced the Company has submitted an initial listing application to the NASDAQ Stock Market to have its common stock approved for listing on the NASDAQ Capital Market. The NASDAQ Stock Market is an American stock exchange which is the second-largest exchange in the world by market capitalization.
Jianfeng Guo, Chief Executive Officer, President and Director of the Company, stated, "Having elected two independent directors to serve on our board and after tax net income expected to reach US$10.00 million in 2015, we are moving forward to uplist on a major international stock exchange in order to provide our current and prospective shareholders with the greater trading liquidity available on an international exchange. We submitted our application to NASDAQ in May 2015."
The Company cannot assure that the listing will be approved.
ABOUT KIRIN INTERNATIONAL HOLDING, INC.
Kirin is a Nevada corporation that operates through its wholly-owned subsidiary, Kirin China, a non-state-owned real estate development company focused on residential and commercial real estate development in "tier-three" cities in the People's Republic of China ("PRC"). Tier-three cities are provincial capital cities with ordinary economic development and prefecture cities with relatively strong economic development. Kirin China's projects are currently concentrated in Hebei Province of the PRC, primarily in the city of Xingtai, and nearby regions. Hebei Province is located in the North Region of the PRC. Kirin China intends to also focus on the Bohai Sea Surrounding Area, which comprises Beijing, Tianjin, Hebei Province, Liaoning Province and Shandong Province
FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" under the federal securities laws. Forward-looking statements, which contain words such as "expect," "intend, "believe," or "plan," by their nature address matters that are, to different degrees, uncertain. These uncertainties may cause actual future events to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
Contact:
Kirin International Holdings
Larry Liu
Vice President
larry.liu@kiringpusa.com
PCG Advisory
Investors:
Kirin Smith, Chief Operating Officer
Ksmith@pcgadvisory.com
D: + 1 646-863-6519
Media:
Sean Leous, Chief Communications Officer
sleous@pcgadvisory.com
D: + 1 646-863-8998
My latest blog - The Three P's of Investing - http://microcapclub.com/2015/07/the-three-ps-of-investing/
SITO Mobile Completes 1-for-10 Reverse Stock Split in Preparation for Uplisting to NASDAQ
JERSEY CITY, N.J., July 30, 2015 (GLOBE NEWSWIRE) -- SITO Mobile Ltd. (SITO) (OTCQB:SITOD), a leading mobile engagement platform provider, announced today that it has effected a 1-for-10 reverse split of its issued and outstanding common stock (the "Reverse Split"), which will be effective July 30, 2015 as a key step in preparation for its planned uplisting to the NASDAQ Capital Market.
"This transaction helps us meet the stock price criteria for our planned uplisting to Nasdaq. We are pleased to have completed the reverse stock split, which we believe will generate better liquidity and attract more investors to our story," said Jerry Hug, CEO of SITO Mobile.
As of today, the Company's common stock will begin trading on a post-split basis, under the symbol "SITOD," with the "D" added for 20 trading days to signify that a reverse stock split has occurred. A new CUSIP number 82988R203 has been assigned to the Company's common stock as a result of the reverse split.
Following the reverse split, every ten shares of the Company's issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock with a par value of $0.001 per share. The total issued and outstanding common shares will be reduced from approximately 163.42 million shares to approximately 16.34 million, subject to adjustment for fractional shares. No fractional shares are to be issued.
About SITO Mobile Ltd.
SITO Mobile provides a mobile engagement platform that enables brands to increase awareness, loyalty and ultimately sales. For more information visit www.sitomobile.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, our reliance on brand owners and wireless carriers, the possible need for additional capital as well other risks identified in our filings with the SEC. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Contact:
Investor and Media Relations:
Robert Haag
IRTH Communications
sito@irthcommunications.com
866-976-4784
Below is my summary of the SCKT earnings and conference call. Based upon their report I expect earnings to grow sequentially in Q3 and possibly in Q4. I expect earnings to grow in 2015 and 2016. I've been buying shares today.
1. EPS made a big jump to $0.07/share on a slight improvement in revenue.
2. Ignoring larger deployments which are lumpy, cordless barcode scanner sales grew 27% YOY. Revenue growth is much better than one would notice by just looking at the top line.
3. The seasonal pattern is going to change this year and going forward because of the 8 series products. The 7 Series products are mostly sold for point-of-sale applications whereas the 8 Series products are sold largely for inventory applications. Sales for inventory applications are greater in Q4 and Q1 which will somewhat offset the point-of-sale seasonal weakness in Q4 and Q1.
4. They received a large $1.6M order for SOMO that will be delivered in Q4 and Q1. They expect more than half of this order to fall in Q4.
5. They expect Q3 revenue to be higher than Q2 revenue. Also, Q4 revenue is likely better than Q3 revenue due to the SOMO order and the seasonality change related to 8 Series products
6. They indicated that the improved GM in Q2 to 47% is sustainable. The margin improvement is due to cost reductions of components. They did indicate that the large SOMO order will have lower margin so expect Q4 overall margin to be perhaps 2% lower.
7. Operating expenses are not expected to increase much as they increase revenue.
8. Growth is expected in 2015 and 2016. In the press release they stated: "We believe 2015 should be a year of growth for Socket Mobile, primarily driven by mobile point of sale as well as an expanding Socket Mobile product portfolio and maturing mobile markets. We believe we are well positioned in our targeted markets and remain focused on increasing our profitability and building the business for further growth in 2016."
Below is my summary of the SCKT earnings and conference call. Based upon their report I expect earnings to grow sequentially in Q3 and possibly in Q4. I expect earnings to grow in 2015 and 2016. I've been buying shares today.
1. EPS made a big jump to $0.07/share on a slight improvement in revenue.
2. Ignoring larger deployments which are lumpy, cordless barcode scanner sales grew 27% YOY. Revenue growth is much better than one would notice by just looking at the top line.
3. The seasonal pattern is going to change this year and going forward because of the 8 series products. The 7 Series products are mostly sold for point-of-sale applications whereas the 8 Series products are sold largely for inventory applications. Sales for inventory applications are greater in Q4 and Q1 which will somewhat offset the point-of-sale seasonal weakness in Q4 and Q1.
4. They received a large $1.6M order for SOMO that will be delivered in Q4 and Q1. They expect more than half of this order to fall in Q4.
5. They expect Q3 revenue to be higher than Q2 revenue. Also, Q4 revenue is likely better than Q3 revenue due to the SOMO order and the seasonality change related to 8 Series products
6. They indicated that the improved GM in Q2 to 47% is sustainable. The margin improvement is due to cost reductions of components. They did indicate that the large SOMO order will have lower margin so expect Q4 overall margin to be perhaps 2% lower.
7. Operating expenses are not expected to increase much as they increase revenue.
8. Growth is expected in 2015 and 2016. In the press release they stated: "We believe 2015 should be a year of growth for Socket Mobile, primarily driven by mobile point of sale as well as an expanding Socket Mobile product portfolio and maturing mobile markets. We believe we are well positioned in our targeted markets and remain focused on increasing our profitability and building the business for further growth in 2016."
From the SCKT PR: "We believe 2015 should be a year of growth for Socket Mobile, primarily driven by mobile point of sale as well as an expanding Socket Mobile product portfolio and maturing mobile markets. We believe we are well positioned in our targeted markets and remain focused on increasing our profitability and building the business for further growth in 2016," Mills concluded.
SCKT reports excellent earnings of $0.07/share!
http://finance.yahoo.com/news/socket-mobile-reports-profitable-second-200100339.html
I'll let you know what the next PFHO is once I figure it out myself.
My latest blog - The Three P's of Investing - http://microcapclub.com/2015/07/the-three-ps-of-investing/
My latest blog - The Three P's of Investing - http://microcapclub.com/2015/07/the-three-ps-of-investing/
That was more like a one-night stand than true love.
Biosyent is getting some love today.
Here is a nice interview with Ian Cassel about being a MicroCap Investor.
http://stocknewsnow.com/podcast.php
I picked up a few more shares of MTSL this morning. I'm buying at a level that is less than management's last purchase. I like buying like that.
I post a lot on twitter. You can follow me there at:
https://twitter.com/MikeDDKing
Cryoport Announces Pricing of Public Offering of Units and Listing on NASDAQ
July 23, 2015 8:41 PM
LAKE FOREST, Calif., July 23, 2015 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the pricing of an underwritten public offering of 2,000,000 units at an offering price of $3.25 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. The common stock and the warrants are immediately separable, and will trade on The Nasdaq Capital Market under the symbols CYRX, and CYRXW, respectively. The warrants will have a per share exercise price of $3.57, are exercisable immediately and will expire five years from the date of issuance.
Gross proceeds to Cryoport from this offering are approximately $6,500,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cryoport. Cryoport has granted the underwriters a 45-day option to purchase up to an additional 300,000 units to cover over-allotments, if any. The offering is expected to close on July 29, 2015, subject to customary closing conditions.
Aegis Capital Corp. is acting as the sole book-running manager for the offering.
Feltl and Company is acting as a co-manager for the offering.
A registration statement on Form S-1 relating to the common stock and warrants was filed with the Securities and Exchange Commission (SEC) and is now effective. A preliminary prospectus relating to the offering, which forms a part of the effective registration statement, has been filed with the SEC and is available on the SEC's web site at http://www.sec.gov. Copies of the final prospectus relating to the offering, when available, may be obtained from the offices of Aegis Capital Corp., Prospectus Department, 810 Seventh Avenue, 18th Floor, New York, NY, 10019, telephone: 212-813-1010 or email: prospectus@aegiscap.com, or from the above-mentioned SEC website.
This press release does not and shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Cryoport, Inc.
Cryoport is the premier provider of cryogenic logistics solutions to the life sciences industry through its purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. We provide leading edge logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide including points-of-care, CRO's, central laboratories, pharmaceutical companies, contract manufacturers, and university researchers. Our packaging is built around our proprietary Cryoport Express® liquid nitrogen dry vapor shippers, which are validated to maintain a constant -150°C temperature for a 10 day dynamic shipment duration. Our information technology centers around our Cryoportal™ Logistics Management Platform, which facilitates management of the entire shipment process. Cryoport is the preferred cryogenic logistics solutions partner to the world's largest shipping companies controlling more than 85% of the world's air shipments. For more information, visit www.cryoport.com.
To download Cryoport's investor relations app, which offers access to SEC documents, press releases, videos, audiocasts and more, please click to download from your iPhone and iPad or Android mobile device.
Forward Looking Statements
Statements in this news release which are not purely historical, including statements regarding Cryoport, Inc.'s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company's business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2015. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cryoport-announces-pricing-of-public-offering-of-units-and-listing-on-nasdaq-300118227.html
This link contains all of my http://microcapclub.com blog posts: http://microcapclub.com/author/mike-schellinger/
More blog posts are coming soon.
XPLT / DAP-U.V is getting some love today.
correct on PSIX
I nibbled a bit on PSIX today at $45.51. I suspect it is a reaction to oil prices although I'm not certain. If it is due to oil prices, then I think this is a good buy here as oil prices impact sales for PSIX less than people think. If it is something else....
I think the biggest impact from oil prices is the use of PSIX engines for generators in the oil patch. The sales there relate more to well completion rather than oil prices. Therefore, oil prices should not have much of a permanent impact on sales in that sector.
In just the past few days I was driving back from vacation. I saw CNG for sale at a rest stop. I think it was in Ohio or Pennsylvania. I believe the price of CNG was $2.09/gallon. I believe the regular gas price was something like $2.80 at that same spot. Whatever, the prices were, it is sufficient to say that CNG was significantly cheaper than gas. Here are some links to corroborate that:
http://www.cngnow.com/average-cng-prices/pages/default.aspx
http://www.pennsylvaniagasprices.com/index.aspx?fuel=D&area=Lancaster&dl=Y&intro=Y
Keep in mind that CNG engines are much cheaper to produce than diesel. Therefore, fuel prices are only one reason of several for conversion.
First Community Financial Partners, Inc. Receives NASDAQ Stock Exchange
JOLIET, Ill., July 15, 2015 (GLOBE NEWSWIRE) -- First Community Financial Partners, Inc. (OTC Pink:FCMP) ("First Community" or the "Company"), the parent company of First Community Financial Bank (the "Bank"), based in Plainfield, Illinois, with six banking offices serving greater Chicagoland, today announced that its common stock has been approved for listing on The NASDAQ Capital Market. The Company expects that the stock will begin trading on NASDAQ on Friday, July 17, 2015, under the newly established ticker symbol "FCFP". The Company’s common stock currently trades over-the-counter under ticker symbol “FCMP”.
Roy Thygesen, Chief Executive Officer, stated: "We believe making the transition to NASDAQ is a logical and prudent step forward for our Company. First Community has been an SEC-reporting corporation for some time now, and our subsidiary Bank’s financial performance has improved markedly in recent years. We have demonstrated earnings growth, and we believe overall financial and operating metrics are trending in the right direction. Reflecting improved financial performance the Company’s stock price, as reported on the OTC Pink Marketplace, appreciated approximately 86% over the past two years. Trading on NASDAQ is expected to increase both retail and institutional investor exposure to the Company, improve trading liquidity for shareholders, and, when appropriate, increase the Company's access to the public and private capital markets to support continued growth of the institution.”
A graph accompanying this release is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/005b38ed-f29d-409e-9a34-dd7dea128fc2
The Company’s focus on generating increased value for shareholders has resulted in a steady increase in the Company’s tangible book value per share from $4.30 at March 31, 2013 to $5.59 at March 31, 2015, which is an increase of 30.0%. Asset quality has improved significantly during this same period, with non-performing assets decreasing $25.9 million or 74.7% since March 31, 2013, to $8.8 million, or 0.91% of total assets, at March 31, 2015.
About First Community Financial Partners, Inc.: First Community Financial Partners, Inc., headquartered in Joliet, Illinois, is a bank holding company whose common stock currently trades on the OTC marketplace (OTC Pink:FCMP). First Community Financial Partners has one bank subsidiary, First Community Financial Bank. First Community Financial Bank, based in Plainfield, Illinois, is a wholly owned banking subsidiary of First Community Financial Partners, with locations in Joliet, Plainfield, Homer Glen, Channahon, Naperville and Burr Ridge, Illinois. The Bank is dedicated to its founding principles by being actively involved in the communities it serves and providing exceptional personal service delivered by experienced local professionals.
Special Note Concerning Forward-Looking Statements
Any statements in this release other than statements of historical facts, including statements about management’s beliefs and expectations, are forward-looking statements and should be evaluated as such. These statements are made on the basis of management’s views and assumptions regarding future events and business performance. Words such as “estimate,” “believe,” “anticipate,” “expect,” “intend,” “plan,” “target,” “project,” “should,” “may,” “will” and similar expressions are intended to identify forward-looking statements. Forward-looking statements (including oral representations) involve risks and uncertainties that may cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. These risks and uncertainties include the ability of First Community and its wholly owned bank subsidiary to realize the synergies from the merger of its non-wholly owned bank subsidiaries, as well as a number of other factors related to the businesses of First Community and its wholly owned bank subsidiary, including: risks associated with First Community’s possible pursuit of acquisitions; economic conditions in First Community’s, and its wholly owned bank subsidiary’s; service areas; system failures; losses of large customers; disruptions in relationships with third party vendors; losses of key management personnel and the inability to attract and retain highly qualified management personnel in the future; the impact of legislation and regulatory changes on the banking industry, including the implementation of the Basel III capital reforms; losses related to cyber-attacks; and liability and compliance costs regarding banking regulations. These and other risks and uncertainties are discussed in more detail in First Community’s filings with the Securities and Exchange Commission, including First Community’s Annual Report on Form 10-K filed on March 13, 2015.
Many of these risks are beyond management’s ability to control or predict. All forward-looking statements attributable to First Community, and its wholly owned bank subsidiary, or persons acting on behalf of each of them are expressly qualified in their entirety by the cautionary statements and risk factors contained in this communication. Because of these risks, uncertainties and assumptions, you should not place undue reliance on these forward-looking statements. Furthermore, forward-looking statements speak only as of the date they are made. Except as required under the federal securities laws or the rules and regulations of the Securities and Exchange Commission, First Community does not undertake any obligation to update or review any forward-looking information, whether as a result of new information, future events or otherwise.
Contact:
Contact: Glen L. Stiteley, Chief Financial Officer - (815) 725-1885
MTSL just traded at the 52 week high.
OML.V / OLNCF reports an excellent Q2 with EPS of $0.05/share.
http://finance.yahoo.com/news/omni-lite-industries-reports-strong-123000759.html
XPLT / DAP-U.V has been performing well lately.
They might be worth following. Unfortunately, I have no idea why they made the purchase.
Sell 3000 shares of USNU for the SwingTrade Portfolio at $0.42.
I found a few more things. Check this out:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=115323372
The commentary in the SYEV commentary is nice:
“The increase in sales to $2.3 million during the three months ended May 31, 2015 from $1.1 million during the three months ended May 31, 2014 (112%) is primarily due the launch of our pH2O product line, which increases the alkalinity of municipal water to between 8.0-9.5 pH. Sales during the three months ended May 31, 2015 of this product line were approximately $1.0 million, compared to nothing in the comparable period 2014. Additionally, we had one customer (who has not purchased any product from the pH2O line) that has developed a private label pitcher and bottle, and significantly increased their distribution line, with sales increasing from $46,000 during the three months ended May 31, 2014 to $576,000 during the three months ended May 31, 2015. As we expand our distribution of the pH2O product line, and continue to strengthen relationships with existing customers, we anticipate improvement in sales volume to continue into subsequent quarters.”
“The product mix and timing of significant sales is always a significant factor in the resulting profit margins reported. [b[The Company expects the gross margin percentages to remain at approximately 50% in the foreseeable future.”
“Additionally, as part of a strategic move to accommodate expected profitable sales growth, we leased additional space for our production and warehousing to a new location,...”
Seychelle Initiates a 1,000,000 Share Buy-Back Program
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--
Seychelle Water Filtration Products, a DBA of Seychelle Environmental Technologies, Inc. (OTC Bulletin Board: SYEV), a worldwide leader in the development, assembly and sale of proprietary portable water filtration bottles made the following announcement today.
We believe that our common shares are currently undervalued. As a result, our Board of Directors has adopted effective January 19, 2015, a common share buy-back program to reduce the number of outstanding shares authorizing our management to enter the market to re-purchase up to 1,000,000 of our common shares at such times and market price or prices as management may deem appropriate. This common share buy-back program will be reviewed by our Board on at least a quarterly basis.
The Stock Broker representing Seychelle in this stock buy-back transaction is Mr. Joey Rocca with Wilson Davis at 801-415-1313.
With Seychelle portable water filtration, consumers can drink, with complete confidence, perfectly filtered water that is great-tasting from a variety of sources – the tap, rivers, streams, ponds or creeks. The regular filter works for water from the tap while the standard and advanced filters are needed for most outdoor uses. The proprietary Seychelle Ionic Adsorption Micron Filtration has been tested extensively by Independent Government Laboratories in the US and throughout the world to strict EPA/ANSI protocols and NSF Standards 42 and 53 by Broward Testing Laboratories.
“Perfectly Filtered Water For a Great Taste and a Healthier Life”
Note to Investors
This press release may contain certain forward-looking information about the Seychelle’s business prospects/projections. These are based upon good-faith current expectations of Seychelle’s management. Seychelle makes no representation or warranty as to the attainability of such assumptions/projections. Investors are expected to conduct their own investigation with regard to Seychelle. Seychelle assumes no obligation to update the information in this press release. For more information, please visit www.seychelle.com or call (949) 234-1999.
Contact:
Seychelle Environmental Technologies, Inc.
Dick Parsons, 949-234-1999
dickparsons@seychelle.com